跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要明确在主分层因果推断框架中处理部分依从性并估计治疗效应。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Leonardo Grilli

主分层框架下用Copula建模部分依从性

研究问题
在治疗与对照下的依从程度均连续、且无法同时观测时,如何建模两者关联并估计部分依从情形下的治疗因果效应?
方法与思路
作者以Plackett copula描述两种潜在依从程度的联合分布,用灵活结局回归及EM极大似然估计,并开展关联参数敏感性分析。
材料陈述的贡献
摘要称该方法允许经验边际分布、交互项和异方差;药物案例的效应估计接近既有分析,但依从程度关联模式有所不同。
阅读关注点
应核对因果效应定义、主分层识别条件、copula设定及剖面似然,并重点检查效应对不可共同观测的依从关联参数的敏感性。
阅读边界
仅据OpenAlex索引摘要,稿件版本未注明。摘要明确关联参数缺乏直接经验支持;效应估计仍依赖模型,不能据此认定关联已被识别。

原文摘要

Within the principal stratification framework for causal inference, modeling partial compliance is challenging because the continuous nature of the principal strata raises subtle specification issues. In this context, we propose an approach based on the assumption that the joint distribution of the degree of compliance to the treatment and the degree of compliance to the control follows a Plackett copula, so that their association is modeled in a flexible way through a single parameter. Moreover, given the two compliances, the distribution of the outcomes is parameterized in a flexible way through a regression model which may include interaction and quadratic terms and may also be heteroscedastic. In order to estimate the parameters of the resulting model, and then the causal effect of the treatment, we adopt a maximum likelihood approach via the EM algorithm. In applying this approach, the marginal distributions of the two compliances are estimated by their empirical distribution functions, so that no constraints are posed on these distributions. Since the two compliances cannot be jointly observed, there is not direct empirical support for the association parameter. We describe a strategy for studying this parameter by a profile likelihood method and discuss an analysis of the sensitivity of the causal inference results to its value. We apply the proposed approach to data from a study about a drug for lowering cholesterol levels previously analyzed by Efron and Feldman and by Jin and Rubin. Estimated causal effects are in line with those of previous analyses, but the pattern of association between the compliances is qualitatively different, apparently due to the flexibility of the copula and to allowing regression equations in the proposed method to include interactions and heteroscedasticity.

笔记与分组
相关领域论文